<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To investigate specific features of extrarenal manifestations of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) in patients with APS-associated <z:hpo ids='HP_0000112'>nephropathy</z:hpo> (APSN) in primary APS and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e>) with secondary APS; to compare clinicomorphological signs of APSN in primary and secondary APS </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIAL AND METHODS: We examined 44 APSN patients with primary APS and 90 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e>: 57 with secondary APS, 33 with <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (<z:chebi fb="21" ids="53713">APA</z:chebi>) without history of <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>In addition to clinical and immunological examination, detection of serological APS markers, morphological examination of renal tissue and ultrasound dopplerography (USDG) of the renal vessels were made (in some patients) for assessment of the condition of intrarenal vascular bed </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: In patients with primary APS, <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">renal disorder</z:e> and secondary APS in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> frequency of <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> doubles that of venous ones </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">Renal disorder</z:e> irrespective of a clinical APS form (primary, secondary) combines with affection of the <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>, heart and skin (livedo) </plain></SENT>
<SENT sid="5" pm="."><plain>This correlates with frequency of <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>In patients with primary APSN rate of arterial <z:hpo ids='HP_0000822'>hypertension</z:hpo> (AH), especially severe, and <z:hpo ids='HP_0000082'>renal dysfunction</z:hpo> is higher than in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> with APS while this group is characterized by more severe <z:hpo ids='HP_0000093'>proteinuria</z:hpo>, <z:hpo ids='HP_0002907'>microhematuria</z:hpo> and higher incidence of <z:hpo ids='HP_0000100'>nephrotic syndrome</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>A direct correlation exists between the incidence of <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> and severity of AH, between AH and <z:e sem="disease" ids="C0920646" disease_type="Disease or Syndrome" abbrv="">renal ischemia</z:e> by USDG </plain></SENT>
<SENT sid="8" pm="."><plain>Morphologically, <z:hpo ids='HP_0000096'>glomerulosclerosis</z:hpo>, marked <z:e sem="disease" ids="C0878486" disease_type="Disease or Syndrome" abbrv="">arteriolosclerosis</z:e> and diffuse interstitial <z:mp ids='MP_0000612'>sclerosis</z:mp> occur more often in patients with primary APSN compared to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> patients with APS </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: In primary and secondary (in SLE) APS combination of APSN with impairment of the <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>, heart and skin, correlation of its basic clinical manifestations with <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> allow us to single out a special clinical variant of APS manifesting with generalized ischemic lesions of the organs as a result of arterial/arteriolar <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>Irrespective of its nature, APSN has common characteristic features--combination of AH, persistent <z:hpo ids='HP_0000082'>renal dysfunction</z:hpo> and transitory <z:e sem="disease" ids="C1328315" disease_type="Disease or Syndrome" abbrv="">hypercreatininemia</z:e>--correlating with development of <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo>; therefore, this pathology can be considered as a variant of thrombotic vascular lesion of the kidneys </plain></SENT>
</text></document>